| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 191 | US 101 | 99.49 |
| Blood Pressure and Hypertension Studies | Lifetime | 149 | US 65 | 99.45 |
| Cardiovascular Syncope and Autonomic Disorders | Lifetime | 67 | US 33 | 99.04 |
| Pharmacology and Obesity Treatment | Lifetime | 70 | US 38 | 98.98 |
| Hormonal Regulation and Hypertension | Lifetime | 223 | US 91 | 98.75 |
| Anesthesia and Sedative Agents | Lifetime | 197 | US 94 | 98.74 |
| Cardiac electrophysiology and arrhythmias | Lifetime | 390 | US 212 | 98.92 |
| Heart Failure Treatment and Management | Lifetime | 244 | US 129 | 99.07 |
| Cardiovascular Issues in Pregnancy | Lifetime | 140 | US 64 | 98.52 |
| Heart Rate Variability and Autonomic Control | Lifetime | 382 | US 179 | 98.62 |
| Lipoproteins and Cardiovascular Health | Lifetime | 272 | US 142 | 98.76 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 530 | US 221 | 98.55 |
| Cardiac pacing and defibrillation studies | Lifetime | 401 | US 204 | 98.81 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 321 | US 132 | 98.46 |
| Infective Endocarditis Diagnosis and Management | Lifetime | 465 | US 215 | 98.18 |
| Inflammatory mediators and NSAID effects | Lifetime | 438 | US 213 | 97.42 |
| Acute Myocardial Infarction Research | Lifetime | 543 | US 244 | 98.37 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 891 | US 341 | 97.99 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 151 | US 85 | 96.43 |
| Cardiac Arrhythmias and Treatments | Lifetime | 952 | US 434 | 97.75 |
| Cardiac Health and Mental Health | Lifetime | 444 | US 225 | 97.09 |
| Cardiac Structural Anomalies and Repair | Lifetime | 924 | US 520 | 97.59 |
| Eicosanoids and Hypertension Pharmacology | Lifetime | 523 | US 264 | 96.94 |
| Hemodynamic Monitoring and Therapy | Lifetime | 662 | US 269 | 96.57 |
| Pericarditis and Cardiac Tamponade | Lifetime | 154 | US 74 | 95.80 |
| Pregnancy and Medication Impact | Lifetime | 340 | US 147 | 96.38 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 613 | US 225 | 96.34 |
| Heart rate and cardiovascular health | Lifetime | 63 | US 23 | 95.70 |
| Cardiac tumors and thrombi | Lifetime | 654 | US 310 | 94.79 |
| Cardiac Ischemia and Reperfusion | Lifetime | 974 | US 409 | 95.00 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 149 | US 50 | 92.86 |
| Apelin-related biomedical research | Lifetime | 294 | US 102 | 92.59 |
| Pharmaceutical Economics and Policy | Lifetime | 622 | US 280 | 93.71 |
| Renin-Angiotensin System Studies | Lifetime | 663 | US 259 | 94.57 |
| Pain Management and Treatment | Lifetime | 459 | US 196 | 92.38 |
| Pharmacological Effects and Assays | Lifetime | 749 | US 274 | 92.41 |
| Potassium and Related Disorders | Lifetime | 413 | US 203 | 92.61 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 563 | US 219 | 90.79 |
| Vitamin K Research Studies | Lifetime | 837 | US 334 | 83.44 |
| Sex and Gender in Healthcare | Lifetime | 473 | US 266 | 79.67 |
| Diabetes Treatment and Management | 2021-2025 | 857 | US 274 | 91.53 |
| Coronary Artery Anomalies | 2021-2025 | 177 | US 62 | 87.18 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 578 | US 150 | 85.69 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 376 | US 154 | 85.88 |
| Hormonal Regulation and Hypertension | 2021-2025 | 497 | US 116 | 86.58 |
| Renin-Angiotensin System Studies | 2021-2025 | 78 | US 31 | 83.32 |
| Cardiac tumors and thrombi | 2021-2025 | 349 | US 120 | 81.74 |
| Pharmacology and Obesity Treatment | 2021-2025 | 282 | US 126 | 80.64 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 186 | US 62 | 76.18 |
| Kawasaki Disease and Coronary Complications | 2021-2025 | 495 | US 121 | 77.82 |
| Atherosclerosis and Cardiovascular Diseases | 2021-2025 | 928 | US 200 | 75.40 |
| Sodium Intake and Health | 2021-2025 | 900 | US 200 | 58.89 |
| Eicosanoids and Hypertension Pharmacology | 2021-2025 | 872 | US 230 | 55.20 |
